foxo4-dri senolytic peptide mechanism Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Buy FOXO4 DRI 10mg Third Party Tested BioEdge Peptides FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC FOXO4 DRI (Proxofim) 10mg*10 vials Nexus peptides Your Gateway To High Quality Peptides
Pay in 4 interest-free payments of $5.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13



